Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vilar

Showing results (101-110 of 3,946) with videos related to

Pageof 395
Sort By:
Alimentary Pharmacology & Therapeutics|January 12, 2017
Editorial: treating the liver to treat the kidney in non-alcoholic steatohepatitis - authors' replyE Vilar-Gomez, N Chalasani
Endocrinology|December 1, 1987
Activation of gamma-aminobutyric acid B-receptors abolishes naloxone-stimulated luteinizing hormone releaseC Masotto, A Negro-Vilar
Clinical Endocrinology|December 1, 1994
Quinagolide efficacy and tolerability in hyperprolactinaemic patients who are resistant to or intolerant of bromocriptineL Vilar, C W Burke
Journal of the American Animal Hospital Association|January 4, 2024
Septic Peritonitis Secondary to Neoplasia in Two Canine Cancer-Bearing Patients Lacking Gastrointestinal and Hepatic Organ RupturePatricia Gualtieri, Paulo Vilar Saavedra
Alimentary Pharmacology & Therapeutics|April 21, 2024
Editorial: Enriching our understanding of MASLD through representation of under-reported populationsNiharika Samala, Eduardo Vilar-Gomez
Journal of the National Cancer Institute|September 20, 2017
Targeted Therapy for Cancer-Associated Fibroblasts: Are We There Yet?Reagan M Barnett, Eduardo Vilar
Brain Research Bulletin|November 1, 1985
Inhibition of spontaneous or angiotensin II-stimulated water intake by atrial natriuretic factorC Masotto, A Negro-Vilar
Nature Reviews. Clinical Oncology|February 10, 2010
Microsatellite instability in colorectal cancer-the stable evidenceEduardo Vilar, Stephen B Gruber
Plos One|April 30, 2026
Type 1 and Type 2 diabetes in the UK press: A diachronic corpus-based analysisSara Vilar-Lluch, Dawn Knight
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 29, 2019
Daily Aspirin Use Reduces Risk of Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease, Providing New Uses for an Old DrugEduardo Vilar-Gomez, Naga Chalasani
Pageof 395

Showing results (101-110 of 3,946) with videos related to

Sort By:
Pageof 395
Alimentary Pharmacology & Therapeutics|January 12, 2017
Editorial: treating the liver to treat the kidney in non-alcoholic steatohepatitis - authors' replyE Vilar-Gomez, N Chalasani
Endocrinology|December 1, 1987
Activation of gamma-aminobutyric acid B-receptors abolishes naloxone-stimulated luteinizing hormone releaseC Masotto, A Negro-Vilar
Clinical Endocrinology|December 1, 1994
Quinagolide efficacy and tolerability in hyperprolactinaemic patients who are resistant to or intolerant of bromocriptineL Vilar, C W Burke
Journal of the American Animal Hospital Association|January 4, 2024
Septic Peritonitis Secondary to Neoplasia in Two Canine Cancer-Bearing Patients Lacking Gastrointestinal and Hepatic Organ RupturePatricia Gualtieri, Paulo Vilar Saavedra
Alimentary Pharmacology & Therapeutics|April 21, 2024
Editorial: Enriching our understanding of MASLD through representation of under-reported populationsNiharika Samala, Eduardo Vilar-Gomez
Journal of the National Cancer Institute|September 20, 2017
Targeted Therapy for Cancer-Associated Fibroblasts: Are We There Yet?Reagan M Barnett, Eduardo Vilar
Brain Research Bulletin|November 1, 1985
Inhibition of spontaneous or angiotensin II-stimulated water intake by atrial natriuretic factorC Masotto, A Negro-Vilar
Nature Reviews. Clinical Oncology|February 10, 2010
Microsatellite instability in colorectal cancer-the stable evidenceEduardo Vilar, Stephen B Gruber
Plos One|April 30, 2026
Type 1 and Type 2 diabetes in the UK press: A diachronic corpus-based analysisSara Vilar-Lluch, Dawn Knight
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 29, 2019
Daily Aspirin Use Reduces Risk of Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease, Providing New Uses for an Old DrugEduardo Vilar-Gomez, Naga Chalasani
Pageof 395